• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒治疗时代HIV感染患者口腔念珠菌分离株的菌种分布及抗真菌药敏谱

Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.

作者信息

Costa Carolina Rodrigues, de Lemos Janine Aquino, Passos Xisto Sena, de Araújo Crystiane Rodrigues, Cohen Ana Joaquina, Souza Lúcia Kioko Hasimoto E, Silva Maria do Rosário Rodrigues

机构信息

Instituto de Patologia Tropical e Saúde Pública da, Universidade Federal de Goiás, Goiás, Brazil.

出版信息

Mycopathologia. 2006 Jul;162(1):45-50. doi: 10.1007/s11046-006-0032-y.

DOI:10.1007/s11046-006-0032-y
PMID:16830191
Abstract

In this study, we investigated the yeasts colonization of genus Candida, including C. dubliniensis, isolated of HIV-infected patients oral cavities and we accessed in vitro susceptibility pattern of the Candida isolates to four antifungal agents. Out of 99 patients investigated, 62 (62.6%) were colonized with yeasts. C. albicans was the prevailing species (50%). C. dubliniensis isolates were not recovered in our study. We verified that 8.1% of the yeasts isolated were resistant to fluconazole, 8.1% to itraconazole and 3.2% to voriconazole. The isolates demonstrated very low voriconazole MICs, in which 79% (49/62) presented values of 0.015 mug/ml. All Candida isolates were susceptible to amphotericin B. The results reported here showed that although C. albicans continues to be present in one-half of oral Candida carriage of HIV-infected patients, Candida non-albicans species are increasing among these patients. Besides, the findings of resistant isolates endorse the role of antifungal susceptibility testing whenever antifungal treatment with azoles is planned.

摘要

在本研究中,我们调查了念珠菌属酵母菌的定植情况,包括从HIV感染患者口腔中分离出的都柏林念珠菌,并评估了念珠菌分离株对四种抗真菌药物的体外药敏模式。在99名接受调查的患者中,62名(62.6%)有酵母菌定植。白色念珠菌是主要菌种(50%)。在我们的研究中未分离到都柏林念珠菌。我们证实,分离出的酵母菌中有8.1%对氟康唑耐药,8.1%对伊曲康唑耐药,3.2%对伏立康唑耐药。分离株的伏立康唑最低抑菌浓度非常低,其中79%(49/62)的值为0.015μg/ml。所有念珠菌分离株对两性霉素B敏感。此处报告的结果表明,尽管白色念珠菌在HIV感染患者口腔念珠菌定植中仍占一半,但非白色念珠菌在这些患者中正在增加。此外,耐药分离株的发现支持了在计划使用唑类抗真菌药物治疗时进行抗真菌药敏试验的作用。

相似文献

1
Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.抗逆转录病毒治疗时代HIV感染患者口腔念珠菌分离株的菌种分布及抗真菌药敏谱
Mycopathologia. 2006 Jul;162(1):45-50. doi: 10.1007/s11046-006-0032-y.
2
Oral Candida isolates among HIV-infected subjects in Nigeria.尼日利亚 HIV 感染者口腔念珠菌分离株。
J Microbiol Immunol Infect. 2011 Jun;44(3):172-7. doi: 10.1016/j.jmii.2011.01.028. Epub 2011 Jan 20.
3
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.对导致HIV患者口咽念珠菌病的非白念珠菌进行分离及药敏试验的意义
Southeast Asian J Trop Med Public Health. 2008 May;39(3):492-5.
4
Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.中国广西地区HIV感染患者在高效抗逆转录病毒治疗第一年期间口腔念珠菌携带、分布及抗真菌药敏的动态分析
J Oral Pathol Med. 2014 Oct;43(9):696-703. doi: 10.1111/jop.12192. Epub 2014 Jun 14.
5
Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.患有口咽念珠菌病的伊朗艾滋病毒/艾滋病患者:念珠菌属的鉴定、患病率及抗真菌药敏性
Lett Appl Microbiol. 2018 Oct;67(4):392-399. doi: 10.1111/lam.13052. Epub 2018 Aug 16.
6
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.在接受氟康唑治疗的口咽念珠菌病的人类免疫缺陷病毒感染患者中,白色念珠菌被都柏林念珠菌取代。
J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002.
7
Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.定植或感染墨西哥艾滋病病毒/艾滋病患者及健康人群的口腔念珠菌分离株的现患率、微生物学及抗真菌药敏模式。
Rev Iberoam Micol. 2005 Jun;22(2):83-92. doi: 10.1016/s1130-1406(05)70014-0.
8
Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代巴西人类免疫缺陷病毒感染患者的口腔念珠菌菌群
Mem Inst Oswaldo Cruz. 2004 Jun;99(4):425-31. doi: 10.1590/s0074-02762004000400014. Epub 2004 Aug 13.
9
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.通过初筛CHROMagar念珠菌培养基及对分离株进行药敏试验检测北美人类免疫缺陷病毒感染患者口咽样本中的都柏林念珠菌。
J Clin Microbiol. 1998 Oct;36(10):3007-12. doi: 10.1128/JCM.36.10.3007-3012.1998.
10
Oral candidiasis of HIV-infected children undergoing sequential HIV therapies.接受序贯抗逆转录病毒治疗的HIV感染儿童的口腔念珠菌病
Med Mycol. 2009 Mar;47(2):149-56. doi: 10.1080/13693780802195315.

引用本文的文献

1
Molecular identification and antifungal susceptibility pattern of species isolated from HIV infected Patients with candisiasis.从感染HIV的念珠菌病患者中分离出的菌种的分子鉴定及抗真菌药敏模式
Curr Med Mycol. 2019 Mar;5(1):21-26. doi: 10.18502/cmm.5.1.533.
2
Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India.印度新德里一家大型三级护理医院中HIV血清阳性患者的念珠菌属流行情况
J Pathog. 2016;2016:6204804. doi: 10.1155/2016/6204804. Epub 2016 Mar 22.
3
Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis.

本文引用的文献

1
Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.土耳其HIV阳性患者口咽样本中都柏林念珠菌的检测
Mycoses. 2005 May;48(3):197-201. doi: 10.1111/j.1439-0507.2005.01125.x.
2
Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.白色念珠菌和都柏林念珠菌中磷脂酶和蛋白酶活性的比较。
Mycoses. 2005 Jan;48(1):62-7. doi: 10.1111/j.1439-0507.2004.01057.x.
3
Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era.
埃塞俄比亚 HIV 感染合并口咽念珠菌病患者酵母菌分离株的菌种谱及体外抗真菌药敏模式
Int J Microbiol. 2016;2016:3037817. doi: 10.1155/2016/3037817. Epub 2016 Jan 5.
4
Antimicrobial activity of complete denture cleanser solutions based on sodium hypochlorite and Ricinus communis - a randomized clinical study.基于次氯酸钠和蓖麻的全口义齿清洁液的抗菌活性——一项随机临床研究
J Appl Oral Sci. 2015 Nov-Dec;23(6):637-42. doi: 10.1590/1678-775720150204.
5
Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis.采用Etest法对从口腔念珠菌病患者中分离出的念珠菌进行药敏试验。
Ann Dermatol. 2015 Dec;27(6):715-20. doi: 10.5021/ad.2015.27.6.715. Epub 2015 Dec 7.
6
Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.台湾中部人类免疫缺陷病毒感染患者的口腔酵母定植。
Mycopathologia. 2014 Jun;177(5-6):309-17. doi: 10.1007/s11046-014-9753-5. Epub 2014 May 8.
7
Conventional and alternative antifungal therapies to oral candidiasis.常规和替代抗真菌疗法治疗口腔念珠菌病。
Braz J Microbiol. 2010 Oct;41(4):824-31. doi: 10.1590/S1517-83822010000400001. Epub 2010 Dec 1.
8
Antifungal suscepitibility profile of candida spp. oral isolates obtained from denture wearers.口腔念珠菌分离株的抗真菌药敏谱分析。
Braz J Microbiol. 2008 Oct;39(4):668-72. doi: 10.1590/S1517-838220080004000013. Epub 2008 Dec 1.
9
Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.中国云南省昆明市 HIV 感染者无症状口腔酵母定植及抗真菌药敏谱。
BMC Infect Dis. 2013 Jan 28;13:46. doi: 10.1186/1471-2334-13-46.
10
Evaluation of antifungal activity of medicinal plant extracts against oral Candida albicans and proteinases.评价药用植物提取物对口腔白色念珠菌和蛋白酶的抗真菌活性。
Mycopathologia. 2011 Aug;172(2):117-24. doi: 10.1007/s11046-011-9404-z. Epub 2011 Mar 16.
高效抗逆转录病毒治疗时代巴西人类免疫缺陷病毒感染患者的口腔念珠菌菌群
Mem Inst Oswaldo Cruz. 2004 Jun;99(4):425-31. doi: 10.1590/s0074-02762004000400014. Epub 2004 Aug 13.
4
Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.斯洛伐克阴道酵母菌分离株对氟康唑和伊曲康唑的敏感性
Mycopathologia. 2004 Feb;157(2):163-9. doi: 10.1023/b:myco.0000020594.35357.b0.
5
Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients.印度人类免疫缺陷病毒阳性患者口腔咽喉部病变中念珠菌属特异性念珠菌的药敏模式及分子类型
J Clin Microbiol. 2004 Mar;42(3):1260-2. doi: 10.1128/JCM.42.3.1260-1262.2004.
6
Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.葡萄牙念珠菌临床分离株对五种全身性抗真菌药物的敏感性
J Antimicrob Chemother. 2004 Mar;53(3):526-9. doi: 10.1093/jac/dkh106. Epub 2004 Feb 12.
7
Candida dubliniensis identification in Brazilian yeast stock collection.巴西酵母菌种保藏中心中都柏林念珠菌的鉴定
Mem Inst Oswaldo Cruz. 2003 Jun;98(4):533-8. doi: 10.1590/s0074-02762003000400020. Epub 2003 Aug 18.
8
Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals.拉丁美洲医院念珠菌属血流分离株的菌种分布及抗真菌药敏谱
Mem Inst Oswaldo Cruz. 2003 Apr;98(3):401-5. doi: 10.1590/s0074-02762003000300020. Epub 2003 Jul 18.
9
In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.伏立康唑、泊沙康唑及四种已获许可的全身用抗真菌药对从血液中罕见分离出的念珠菌属的体外活性。
J Clin Microbiol. 2003 Jan;41(1):78-83. doi: 10.1128/JCM.41.1.78-83.2003.
10
Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method.采用纸片扩散法评估巴西念珠菌分离株对氟康唑的敏感性。
Braz J Infect Dis. 2002 Jun;6(3):118-23. doi: 10.1590/s1413-86702002000300003.